Working… Menu

Tocilizumab REMission in Early RA (TREMERA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04157010
Recruitment Status : Completed
First Posted : November 8, 2019
Last Update Posted : November 8, 2019
Hoffmann-La Roche
Information provided by (Responsible Party):
Dr Maya Buch, University of Leeds

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 29, 2016
Actual Study Completion Date : March 29, 2016